Skip to content

Surgical site infection following abdominal surgery: A randomized control trial comparing common dressing and antimicorobial dressing containing ionic silver (Aquacel Ag Hydrofiber)

Surgical site infection following abdominal surgery: A randomized control trial comparing common dressing and antimicorobial dressing containing ionic silver (Aquacel Ag Hydrofiber) - Surgical site infection following abdominal surgery: A randomized control trial comparing common dressing and antimicorobial dressing containing ionic silver (Aquacel Ag Hydrofiber)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043081
Enrollment
800
Registered
2022-03-31
Start date
2013-12-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing abdominal digestive surgery

Interventions

After the skin closure, Aquacel Ag hydrofiber, width of 1.0-1.5 cm in diameter, is placed over the incision and covered with a film dressing to the patients assigned to Ag group. After 48 hours from

Sponsors

Department of Surgery, Teikyo University Chiba Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) elective or emergent digestive surgery. 2)age 15 years or older. 3)Patients undergoing laparoscopic surgery or open surgery. 4)Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1

Exclusion criteria

Exclusion criteria: patients with the following levels of bone marrow, hepatic, and renal function based on the data obtained within 1 week before enrollment. 1)white blood cell count <4,000/mm3 and >12,000mm3 2)platelet count <100,000mm3 3)hemoglobin <9.0 g/dL 4)total bilirubin >2.0 mg/dL, asparate aminotransferase (AST) / glutamate oxaloacetate transaminase (GOT) > 100 IU/L, alanine aminotransferase (AST) / glutamate pyruvate transaminase (GPT) >100 IU/L 5)serum creatinine below the institutional upper limit of normal

Design outcomes

Primary

MeasureTime frame
The incidence of superficial SSI comparing between Aquacel Ag Hydrofiber dressing group and topical agent group within 30 days after digestive surgery.

Secondary

MeasureTime frame
The comparison of the incidence of superficial SSI in the patient's characteristics of clinical and surgical features.

Countries

Japan

Contacts

Public ContactChihiro Kosugi

Teikyo University Chiba Medical Center Department of Surgery

ckosugi0126@yahoo.co.jp0436-62-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026